المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - cilazapril monohydrate - oral tablet - 5mg

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 5.213mg equivalent to 5 mg cilazapril - film coated tablet - 5 mg - active: cilazapril monohydrate 5.213mg equivalent to 5 mg cilazapril excipient: hyprolose hypromellose iron oxide red macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg;   - tablet - 1 mg - active: cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f92084 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg;   - tablet - 2.5 mg - active: cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 85f14364 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 5.215mg equivalent to cilazapril 5 mg;   - tablet - 5 mg - active: cilazapril monohydrate 5.215mg equivalent to cilazapril 5 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry brown 85f16874 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

كندا - الإنجليزية - Health Canada

apotex inc - cilazapril (cilazapril monohydrate); hydrochlorothiazide - tablet - 5mg; 12.5mg - cilazapril (cilazapril monohydrate) 5mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

كندا - الإنجليزية - Health Canada

cobalt pharmaceuticals company - cilazapril (cilazapril monohydrate) - tablet - 1.0mg - cilazapril (cilazapril monohydrate) 1.0mg - angiotensin-converting enzyme inhibitors

كندا - الإنجليزية - Health Canada

cobalt pharmaceuticals company - cilazapril (cilazapril monohydrate) - tablet - 2.5mg - cilazapril (cilazapril monohydrate) 2.5mg - angiotensin-converting enzyme inhibitors

كندا - الإنجليزية - Health Canada

cobalt pharmaceuticals company - cilazapril (cilazapril monohydrate) - tablet - 5.0mg - cilazapril (cilazapril monohydrate) 5.0mg - angiotensin-converting enzyme inhibitors

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril - film coated tablet - 1 mg - active: cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril excipient: hyprolose hypromellose iron oxide yellow macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate titanium dioxide - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.